Abstract:OBJECTIVE:To investigate the inhibitory effects of RNA silencing via plasmid-mediated vascular endothelial growth factor (VEGF) shRNA on proliferation of glioma cells in vitro and in vivo.METHODS:pEGFP-H1/VEGF vector plasmid containing enhanced green fluorescent protein (EGFP) gene and expressing VEGF shRNA was constructed. The EGFP expression was detected by fluorescent microscopy and flow cytometry. Glioma cells of the line U251 were cultured and divided into 3 groups to be transfected with blank vector, pEGFP/H1plasmid, and pEGFP-H1/VEGF respectively. RT-PCR was used to detect the mRNA expression of VEGF in the supernatants of the culture media. The protein expression of VEGF in the supernatant was detected by ELISA. The cell growth was observed with MTT method. Fifteen nude rats were randomly divided into 3 equal groups to be transplanted with U251 cells and pEGFP-H1, U251 cells and pEGFP-H1/VEGF, and U251 cells only as blank control group. The growth of glioma was observed every day. 30 days after the rats were killed and the tumors were taken out to be examined.RESULTS:Twenty-four hours after transplantation, fluorescence microscopy showed great numbers of U251 cells that expressed green fluorescence in both the pEGFP-H1 group and pEGFP-H1/VEGF group. Flow cytometry showed that the rates of green fluorescent protein positive cells were 68.37% and 65.29% in these 2 groups (P > 0.05). MTT method showed no significant difference in the effect on cell growth among the 3 groups (all P > 0.05). PCR showed that the VEGF mRNA expression was significantly inhibited in the pEGFP-H1/VEGF group in comparison with those in the blank control group and the group transfected with pEGFP-H1 (both P < 0.05). The concentration of VEGF protein of the U251 cells transfected with pEGFP-H1/VEGF was 530 ng/L +/- 118 ng/L, significantly lower than those of the control group (2571 ng/L +/- 572 ng/L) and the group transfected with pEGFP-H1 (2402 ng/L +/- 310 ng/L, by 77.9%) (both P < 0.01). Tumor could be touched 13 days after transplantation in the rats of pEGFP-H1/VEGF group, markedly later than in the other 2 groups. Thirty days after, the weight and volume of tumor were 0.5 g +/- 0.4 g and 401 mm(3) +/- 272 mm(3) respectively in the rats of pEGFP-H1/VEGF group, both significantly lower than those of the control group and pEGFP-H1 group (1.7 g +/- 0.4 g and 1573 mm(3) +/- 330 mm(3); and 1.5 g +/- 0.7 g and 1430 mm(3) +/- 382 mm(3)) (all P < 0.01).CONCLUSION:The successfully constructed shRNA targeting at VEGF efficiently decreases the VEGF expression of the glioma cells in vitro and suppresses the growth of glioma cells in vivo.

Short Hairpin RNA Targeting Vascular Endothelial Growth Factor Inhibits Expression of Vascular Endothelial Cell in Human GBC-SD Cells

Short Hairpin RNA Targeting Vascular Endothelial Growth Factor Effectively Inhibits Expression of Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelium

Inhibition of VEGFR-1 Gene Expression in U937 Cell Line Using Lentivirus-mediated Shrna

Construction of Targeting-VEGF shRNA Plasmid and Observation of its Inhibitory Effect on Tca8113 Cells

[Inhibition of VEGF Expression by Plasmid-Based RNA Interference in the Retinoblastoma Cells].

Knockdown of VEGF-A expression in neuroblastoma cell line SH-SY5Y by RNA interference

[Effect of VEGFR1 Gene Silencing by Shrna on Proliferation, Migration and Apoptosis of U937 Line].

Hvegf Sirna Inhibits Initial Growth of A549 Tumor Cells in Nude Mice and Angiogenesis on CAM Assay

Inhibition of Vascular Endothelial Growth Factor A Expression in Mouse Granulosa Cells by Lentivector-Mediated RNAi.

The Generation of Eukaryotic Expression Vector of ShRNA Specific for VEGF Receptors Flt-1 and KDR

Inhibition of GnT-V gene expression in BGC823 cell line by using Lentivirus-mediated shRNA

Efficient inhibition of non-small-cell lung cancer xenograft by systemic delivery of plasmid-encoding short-hairpin RNA targeting VEGF.

Vascular Endothelial Growth Factor Shrna Mediated by Pegfp-H1 Vector Plasmid Effectively Inhibits Glioma Proliferation: an Experimental Study

Effects of Shrna Targeting VEGF on VEGF Mrna Expression in Gastric Cancer Cells

Construction of Eukaryotic Expression Plasmid Expressing Shrna Targeting VEGF and NGF

Construction and Assessment of Short-Hairpin Rna Eukaryotic Expression Vector Targeting Tgf-Beta 1 Labeled by Gfp

Effect of knockdown of VEGF gene expression by shRNA on characteristics of human colorectal cancer cell line

RNAi-mediated Knockdown of Vascular Endothelial Growth Factor Inhibits Vascularization and Tumor Growth in Renal Cell Carcinoma

Suppression of HCT116 cell proliferation by silencing vascular endothelial growth factor gene with RNA interference

Effect of small interference RNA on vascular endothelial growth factor expression by glioma U251 cells cultured in vitro

Construction and Expression of Eukaryotic Expression Plasmids of Shrna Targeting the PPARγ Gene